Hepatocellular carcinoma 2009 and beyond: from the surveillance to molecular targeted therapy

M Kudo - Oncology, 2008 - karger.com
Hepatocellular carcinoma (HCC) is a malignant tumor which is becoming more prevalent
worldwide. Patients at high risk of developing HCC, namely hepatitis B-and C-related liver …

Enhancement of hexokinase II inhibitor-induced apoptosis in hepatocellular carcinoma cells via augmenting ER stress and anti-angiogenesis by protein disulfide …

SJ Yu, JH Yoon, JI Yang, EJ Cho, MS Kwak… - Journal of bioenergetics …, 2012 - Springer
bromopyruvate (3-BP), a hexokinase (HK) II inhibitor, promotes tumor cell death by inducing
endoplasmic reticulum (ER) stress in human hepatocellular carcinoma (HCC) cell lines …

[HTML][HTML] Molecular targeted therapy with transarterial chemoembolization

SJ Yu, JH Yoon - Gastrointestinal Intervention, 2013 - Elsevier
Hepatocellular carcinoma (HCC) remains the third most common cause of cancer-related
deaths worldwide, although improvements in patient stratification and the introduction of …

Anti-angiogenesis activities of dietary constituents and health foods with potential anti-hepatocellular carcinoma activity

T Shizuma, N Fukuyama - Recent Patents on Biomarkers, 2012 - ingentaconnect.com
Hepatocellular carcinoma (HCC) is typically a hypervascular tumor with a high mortality rate,
and angiogenesis is considered key to its occurrence and progression. Intrinsic angiogenic …

[PDF][PDF] Gastrointestinal Intervention

SJ Yu, JH Yoon - 2013 - cyberleninka.org
abstract Hepatocellular carcinoma (HCC) remains the third most common cause of cancer-
related deaths worldwide, although improvements in patient stratification and the …